About Ileana Pirozzi
Dr. Ileana Pirozzi is with Lingotto Innovation and is a member of the Multiply Labs board of directors. Multiply Labs builds robotic clusters that automate manual steps in making biologics, including cell and gene therapies, antibodies, viral vectors, and mRNA therapies. Lingotto was a new investor in the company's $75 million Series B, announced October 6, 2026.
In the release, Pirozzi said robotics could replace highly manual work in biomanufacturing with precise, scalable production systems, as it did in automotive and semiconductor manufacturing. Pirozzi added that Multiply Labs has built the technology and real-world deployments to lead that shift, which is why the backers chose it.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Ileana Pirozzi in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Ileana Pirozzi works with at each company, as listed on that company's latest Form D.
